+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global In-Vitro Fertilization Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018-2026

  • ID: 4772956
  • Report
  • Region: Global
  • Acute Market Reports
1 of 3

FEATURED COMPANIES

  • Boston IVF
  • Cook Medical, Inc.
  • Cooper Surgical, Inc.
  • EMD Serono, Inc.
  • Genea Biomedx
  • Irvine Scientific, Inc.
  • MORE
The global in-vitro fertilization market is set to reach from US$ 15,604.7 million in 2017 to US$ 36,854.0 million by 2026 expanding at a CAGR of 10.1% from 2018 to 2026.

Market Insights
Government healthcare institutes and hospitals are actively involved in providing funds to encourage egg and sperm freezing to bring down the rate of multiple pregnancies. Recent technological advancement in in-vitro fertilization technique such as Intracytoplasmic Sperm Injection (ICSI) and Assisted Reproductive Technology (ART) are being employed to increase the success rate of IVF treatment.

Culture media are holding the largest market by an instrument in the in-vitro fertilization market. The chief attributing factors are increased research activities in improving the culture media and its capability to preserve sperm cells without compromising on the quality drive the market growth for culture media. Strict regulatory mandates and urging need to maintain optimum sterile condition during IVF treatment will propel the market growth for disposable devices at a rapid pace.

Fresh non-donor is reigning the type segment for in-vitro fertilization market on account of the high success rate achieved during the first attempt of the treatment protocol. Frozen non-donor will be growing at a rapid pace in the near future owing to excellent live birth rate, lower miscarriage rate and reduced cases of ectopic pregnancy.

Fertility clinics are dominating the end user segment for in-vitro fertilization market. Significant rise in couples opting for ART treatment and Gamete Intrafallopian Transfer (GIFT) drive the market growth for infertility clinics. Hospitals are showcasing steady growth on account of enhanced government funding to provide IVF treatment to poor families and rising public health awareness pertaining to infertility treatment.

North America currently holds a 35% share and is the leading regional segment for in-vitro fertilization market. Rising prevalence of infertility and the existence of highly sophisticated fertility clinics drive the market growth in the North America region. As per the research citings of American Society for Reproductive Medicine (ASRM), approximately 11.0% reproductive population suffer from infertility in the United States. Europe holds a 30% market share on account of proactive government initiatives of providing financial aid for sponsoring the cost incurred during the IVF cycles. The Asia Pacific represents 20% share owing to the presence of a large target population suffering from infertility. Adoption of sophisticated technology and low treatment cost further bolster the market growth in the Asia Pacific region.

Biopharmaceuticals specializing in in-vitro fertilization market are Boston IVF, Cook Medical, Inc., Cooper Surgical, Inc., EMD Serono, Inc., Genea Biomedx, Irvine Scientific, Inc., OvaScience, Inc., Progyny, Inc., Thermo Fisher Scientific, Inc. and Vitrolife AB.

Key Market Movements:
  • Rising prevalence of infertility and increasing trend of late child planning
  • Technological advancement in the different treatment protocol pertaining to in-vitro fertilization
  • Proactive government initiatives to establish fertility clinics and hospitals
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Boston IVF
  • Cook Medical, Inc.
  • Cooper Surgical, Inc.
  • EMD Serono, Inc.
  • Genea Biomedx
  • Irvine Scientific, Inc.
  • MORE
Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global In-Vitro Fertilization Market Portraiture
2.2. Global In-Vitro Fertilization Market, by Instrument, 2017 (US$ Mn)
2.3. Global In-Vitro Fertilization Market, by Type, 2017 (US$ Mn)
2.4. Global In-Vitro Fertilization Market, by End User, 2017 (US$ Mn)
2.5. Global In-Vitro Fertilization Market, by Geography, 2017 (US$ Mn)

Chapter 3. In-Vitro Fertilization Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global In-Vitro Fertilization Market, by Key Players, 2017

Chapter 4. Global In-Vitro Fertilization Market, by Instrument
4.1. Overview
4.2. Disposable Devices
4.3. Culture Media
4.4. Capital Equipment

Chapter 5. Global In-Vitro Fertilization Market, by Type
5.1. Overview
5.2. Fresh Donor
5.3. Frozen Donor
5.4. Fresh Non-Donor
5.5. Frozen Non-Donor

Chapter 6. Global In-Vitro Fertilization Market, by End User
6.1. Overview
6.2. Fertility Clinics
6.3. Hospitals

Chapter 7. Global In-Vitro Fertilization Market, by Geography
7.1. Overview
7.2. North America In-Vitro Fertilization Market Analysis, 2016-2026
7.2.1. North America In-Vitro Fertilization Market, by Instrument, 2016-2026 (US$ Mn)
7.2.2. North America In-Vitro Fertilization Market, by Type, 2016-2026 (US$ Mn)
7.2.3. North America In-Vitro Fertilization Market, by End User, 2016-2026 (US$ Mn)
7.2.4. North America In-Vitro Fertilization Market, by Country, 2016-2026 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe In-Vitro Fertilization Market Analysis, 2016-2026
7.3.1. Europe In-Vitro Fertilization Market, by Instrument, 2016-2026 (US$ Mn)
7.3.2. Europe In-Vitro Fertilization Market, by Type, 2016-2026 (US$ Mn)
7.3.3. Europe In-Vitro Fertilization Market, by End User, 2016-2026 (US$ Mn)
7.3.4. Europe In-Vitro Fertilization Market, by Country/Region, 2016-2026 (US$ Mn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. Rest of Europe
7.4. Asia Pacific In-Vitro Fertilization Market Analysis, 2016-2026
7.4.1. Asia Pacific In-Vitro Fertilization Market, by Instrument, 2016-2026 (US$ Mn)
7.4.2. Asia Pacific In-Vitro Fertilization Market, by Type, 2016-2026 (US$ Mn)
7.4.3. Asia Pacific In-Vitro Fertilization Market, by End User, 2016-2026 (US$ Mn)
7.4.4. Asia Pacific In-Vitro Fertilization Market, by Country/Region, 2016-2026 (US$ Mn)
7.4.4.1. China
7.4.4.2. Japan
7.4.4.3. Rest of Asia Pacific
7.5. Latin America In-Vitro Fertilization Market Analysis, 2016-2026
7.5.1. Latin America In-Vitro Fertilization Market, by Instrument, 2016-2026 (US$ Mn)
7.5.2. Latin America In-Vitro Fertilization Market, by Type, 2016-2026 (US$ Mn)
7.5.3. Latin America In-Vitro Fertilization Market, by End User, 2016-2026 (US$ Mn)
7.5.4. Latin America In-Vitro Fertilization Market, by Country/Region, 2016-2026 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East and Africa In-Vitro Fertilization Market Analysis, 2016-2026
7.6.1. MEA In-Vitro Fertilization Market, by Instrument, 2016-2026 (US$ Mn)
7.6.2. MEA In-Vitro Fertilization Market, by Type, 2016-2026 (US$ Mn)
7.6.3. MEA In-Vitro Fertilization Market, by End User, 2016-2026 (US$ Mn)
7.6.4. MEA In-Vitro Fertilization Market, by Country/Region, 2016-2026 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA

Chapter 8. Company Profiles
8.1. Boston IVF
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. News Coverage
8.2. Cook Medical, Inc.
8.3. Cooper Surgical, Inc.
8.4. EMD Serono, Inc.
8.5. Genea Biomedx
8.6. Irvine Scientific, Inc.
8.7. OvaScience, Inc.
8.8. Progyny, Inc.
8.9. Thermo Fisher Scientific, Inc.
8.10. Vitrolife AB

List of Figures
Figure 1: In-Vitro Fertilization Market: Research Methodology
Figure 2: In-Vitro Fertilization: Market Segmentation
Figure 3: Global In-Vitro Fertilization Market, by Instrument, 2017 (US$ Mn)
Figure 4: Global In-Vitro Fertilization Market, by Type, 2017 (US$ Mn)
Figure 5: Global In-Vitro Fertilization Market, by End User, 2017 (US$ Mn)
Figure 6: Global In-Vitro Fertilization Market, by Geography, 2017 (US$ Mn)
Figure 7: Attractive Investment Proposition: by Geography, 2017
Figure 8: Competitive Analysis: Global In-Vitro Fertilization Market, by Key Players, 2017
Figure 9: Global Disposable Devices Market for In-Vitro Fertilization, 2016-2026 (US$ Mn)
Figure 10: Global Culture Media Market for In-Vitro Fertilization, 2016-2026 (US$ Mn)
Figure 11: Global Capital Equipment Market for In-Vitro Fertilization, 2016-2026 (US$ Mn)
Figure 12: Global Fresh Donor Market for In-Vitro Fertilization, 2016-2026 (US$ Mn)
Figure 13: Global Frozen Donor Market for In-Vitro Fertilization, 2016-2026 (US$ Mn)
Figure 14: Global Fresh Non-Donor Market for In-Vitro Fertilization, 2016-2026 (US$ Mn)
Figure 15: Global Frozen Non-Donor Market for In-Vitro Fertilization, 2016-2026 (US$ Mn)
Figure 16: Global Fertility Clinics Market for In-Vitro Fertilization, 2016-2026 (US$ Mn)
Figure 17: Global Hospitals Market for In-Vitro Fertilization, 2016-2026 (US$ Mn)
Figure 18: U.S. In-Vitro Fertilization Market, 2016-2026 (US$ Mn)
Figure 19: Canada In-Vitro Fertilization Market, 2016-2026 (US$ Mn)
Figure 20: U.K. In-Vitro Fertilization Market, 2016-2026 (US$ Mn)
Figure 21: Germany In-Vitro Fertilization Market, 2016-2026 (US$ Mn)
Figure 22: Rest of Europe In-Vitro Fertilization Market, 2016-2026 (US$ Mn)
Figure 23: China In-Vitro Fertilization Market, 2016-2026 (US$ Mn)
Figure 24: Japan In-Vitro Fertilization Market, 2016-2026 (US$ Mn)
Figure 25: Rest of Asia Pacific In-Vitro Fertilization Market, 2016-2026 (US$ Mn)
Figure 26: Brazil In-Vitro Fertilization Market, 2016-2026 (US$ Mn)
Figure 27: Mexico In-Vitro Fertilization Market, 2016-2026 (US$ Mn)
Figure 28: Rest of Latin America In-Vitro Fertilization Market, 2016-2026 (US$ Mn)
Figure 29: GCC In-Vitro Fertilization Market, 2016-2026 (US$ Mn)
Figure 30: Rest of MEA In-Vitro Fertilization Market, 2016-2026 (US$ Mn)

List of Tables
Table 1: Global In-Vitro Fertilization Market Portraiture
Table 2: Global In-Vitro Fertilization Market, by Instrument, 2016-2026 (US$ Mn)
Table 3: Global In-Vitro Fertilization Market, by Type, 2016-2026 (US$ Mn)
Table 4: Global In-Vitro Fertilization Market , by End User, 2016-2026 (US$ Mn)
Table 5: Global In-Vitro Fertilization Market, by Geography, 2016-2026 (US$ Mn)
Table 6: North America In-Vitro Fertilization Market, by Instrument, 2016-2026 (US$ Mn)
Table 7: North America In-Vitro Fertilization Market, by Type, 2016-2026 (US$ Mn)
Table 8: North America In-Vitro Fertilization Market, by End User, 2016-2026 (US$ Mn)
Table 9: North America In-Vitro Fertilization Market, by Country, 2016-2026 (US$ Mn)
Table 10: Europe In-Vitro Fertilization Market, by Instrument, 2016-2026 (US$ Mn)
Table 11: Europe In-Vitro Fertilization Market, by Type, 2016-2026 (US$ Mn)
Table 12: Europe In-Vitro Fertilization Market, by End User, 2016-2026 (US$ Mn)
Table 13: Europe In-Vitro Fertilization Market, by Country/Region, 2016-2026 (US$ Mn)
Table 14: Asia Pacific In-Vitro Fertilization Market, by Instrument, 2016-2026 (US$ Mn)
Table 15: Asia Pacific In-Vitro Fertilization Market, by Type, 2016-2026 (US$ Mn)
Table 16: Asia Pacific In-Vitro Fertilization Market, by End User, 2016-2026 (US$ Mn)
Table 17: Asia Pacific In-Vitro Fertilization Market, by Country/Region, 2016-2026 (US$ Mn)
Table 18: Latin America In-Vitro Fertilization Market, by Instrument, 2016-2026 (US$ Mn)
Table 19: Latin America In-Vitro Fertilization Market, by Type, 2016-2026 (US$ Mn)
Table 20: Latin America In-Vitro Fertilization Market, by End User, 2016-2026 (US$ Mn)
Table 21: Latin America In-Vitro Fertilization Market, by Country/Region, 2016-2026 (US$ Mn)
Table 22: Middle East and Africa In-Vitro Fertilization Market, by Instrument, 2016-2026 (US$ Mn)
Table 23: Middle East and Africa In-Vitro Fertilization Market, by Type, 2016-2026 (US$ Mn)
Table 24: Middle East and Africa In-Vitro Fertilization Market, by End User, 2016-2026 (US$ Mn)
Table 25: Middle East and Africa In-Vitro Fertilization Market, by Country/Region, 2016-2026 (US$ Mn)
Table 26: Boston IVF: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 27: Cook Medical, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 28: Cooper Surgical, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 29: EMD Serono, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 30: Genea Biomedx: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 31: Irvine Scientific, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 32: OvaScience, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 33: Progyny, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 34: Thermo Fisher Scientific, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 35: Vitrolife AB: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Boston IVF
  • Cook Medical, Inc.
  • Cooper Surgical, Inc.
  • EMD Serono, Inc.
  • Genea Biomedx
  • Irvine Scientific, Inc.
  • OvaScience, Inc.
  • Progyny, Inc.
  • Thermo Fisher Scientific, Inc.
  • Vitrolife AB
Note: Product cover images may vary from those shown
Adroll
adroll